Leber hereditary optic neuropathy, also known as LHON or Leber optic neuropathy, is an inherited genetic condition. It often causes loss of central vision, starting in one eye and eventually affecting ...
Sudden onset of optic neuropathy in the elderly is most frequently vascular in aetiology; however, when bilateral, the diagnosis of LHON should still be considered. We report the oldest documented ...
Please provide your email address to receive an email when new articles are posted on . Idebenone has a Prescription Drug User Fee Act date of Feb. 28, 2026. Positive results in the phase 3 RHODOS and ...
Please provide your email address to receive an email when new articles are posted on . NR082, a gene therapy drug candidate for the treatment of Leber hereditary optic neuropathy, was granted orphan ...
Idebenone (Raxone, Chiesi) is indicated for the 'treatment of visual impairment in adolescent and adult patients with Leber's hereditary optic neuropathy (LHON)'. The list price for a 180 tablets pack ...
"Leber's Hereditary Optic Neuropathy (LHON) Pipeline 2025"DelveInsight's,“Leber's Hereditary Optic Neuropathy - Pipeline Insight, 2025,” report provides comprehensive insights about 6+ companies and ...
There is a simple discount patient access scheme for idebenone. NHS organisations can get details on the Commercial Access and Pricing (CAP) Portal. Non-NHS organisations can contact ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback